Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 392 | 460 | 122 | 0 | 40 |
| Cost of Goods | 244 | 298 | 85 | N/A | 16 |
| Gross Profit | 148 | 162 | 37 | N/A | 24 |
| Operating Expenses | 3,305 | 3,093 | 0 | 0 | 1,595 |
| Operating Income | -2,913 | -2,633 | -2,756 | N/A | -1,554 |
| Interest Expense | 24 | 25 | 14 | 0 | 2 |
| Pre-tax Income | -2,937 | -2,658 | -2,769 | 0 | -1,556 |
| Income Tax | N/A | 2 | N/A | N/A | 16 |
| Net Income Continuous | -2,937 | -2,660 | N/A | N/A | -1,572 |
| Minority Interests | -332 | -72 | N/A | N/A | N/A |
| Net Income | $-2,605 | $-2,587 | $N/A | $N/A | $-1,572 |
| EPS Basic Total Ops | -0.46 | -3.54 | -3.84 | N/A | -3.72 |
| EPS Basic Continuous Ops | -0.52 | -3.66 | N/A | N/A | -3.72 |
| EPS Diluted Total Ops | -0.46 | -3.54 | -3.84 | N/A | -3.72 |
| EPS Diluted Continuous Ops | -0.52 | -3.66 | N/A | N/A | -3.72 |
| EBITDA(a) | $-2,860 | $-2,540 | $122 | $N/A | $-1,539 |